ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near San Diego, CA, USA:

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

therapy in participants with metastatic castration-resistant prostate cancer (mCRPC) comprising 2 phases: a Phase 1 Dose Escalation...

Enrolling
Prostate Cancer Metastatic
Biological: HB-302/HB-301 Alternating 2-Vector Therapy

Phase 1, Phase 2

Hookipa Biotech

San Marcos, California, United States and 9 other locations

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

San Diego, California, United States and 107 other locations

The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer...

Enrolling
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

San Diego, California, United States and 4 other locations

single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate...

Enrolling
Metastatic Cancer
Castration-resistant Prostate Cancer
Drug: Cabozantinib
Drug: Nivolumab

Phase 2

Rana McKay, MD

La Jolla, California, United States and 2 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Enrolling
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Arvinas
Arvinas

La Jolla, California, United States and 22 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

San Diego, California, United States and 131 other locations

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + olaparib

Phase 2

Xencor
Xencor

San Diego, California, United States and 16 other locations

enzalutamide or abiraterone/prednisone alone in asymptomatic or mildly symptomatic subjects with progressive, metastatic castration-resistant prostate...

Active, not recruiting
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Drug: Tazemetostat
Drug: Abiraterone/prednisone

Phase 1, Phase 2

Epizyme

San Diego, California, United States and 23 other locations

impact of intense androgen deprivation on radical prostatectomy (RP) pathologic response and radiographic and tissue biomarkers in localized prostate...

Active, not recruiting
Prostate Cancer
Drug: Apalutamide
Drug: Prednisone

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

La Jolla, California, United States and 3 other locations

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC and SGC.

Active, not recruiting
Prostatic Disease
Salivary Gland Cancer
Drug: Rimiducid
Biological: P-PSMA-101 CAR-T cells

Phase 1

Poseida Therapeutics

San Diego, California, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems